Skip to content
OpenCapital
Get started

Xenon Pharmaceuticals XENE Q3 2025 earnings

Reported November 3, 2025 · After market close

Revenue-
EPS-$1.15Beat by $0.01
EPS estimate-$1.16

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$1.7M
EPS estimate-$1.16

Financials

Q3 2025

Income statement

See full
Revenue-—
Operating income-$96.3M-30.8%
Net income-$90.9M-44.8%
EPS (diluted)-$1.15-42.0%

Balance sheet

See full
Cash & equivalents$104.5M+19.3%
Total debt$8.3M-14.9%
Total equity$559.5M-29.9%
Total assets$607.8M-27.3%

Cash flow

See full
Operating cash flow-$71.8M-44.5%
CapEx$281.0K-52.4%
Free cash flow-$72.0M-43.3%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.1B+1.2%
Enterprise value$3B+0.7%
P/S412.8×—

Profitability

See full
Operating margin-4,543.7%—
Net margin-4,084.5%—
FCF margin-3,377.1%—

Returns & leverage

See full
Return on equity-45.1%+48.3pp
Debt / equity0×0.0×
Current ratio12.5×-9.7×

Versus estimates

Revenue

Q1 2025$7.5MBeat by $5.6M

Diluted EPS

Q1 2026-$1.17In lineQ4 2025-$1.31Miss by $0.11
Q3 2025-$1.15Beat by $0.01
Q2 2025-$1.07Miss by $0.04Q1 2025-$0.83Beat by $0.11Q4 2024-$0.84Beat by $0.05

Ask the moment Xenon Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Xenon Pharmaceuticals report Q3 2025 earnings?
Xenon Pharmaceuticals (XENE) reported Q3 2025 earnings on November 3, 2025 after market close.
What were Xenon Pharmaceuticals's Q3 2025 revenue and EPS?
Xenon Pharmaceuticals reported revenue of - and eps of $-1.15 for Q3 2025.
Did Xenon Pharmaceuticals beat estimates in Q3 2025?
EPS beat the consensus estimate of $-1.16 by $0.01.
How did Xenon Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 42.0% from $-0.81.
Where can I find Xenon Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-262519) and the 10-Q periodic report (0001193125-25-262646) directly on SEC EDGAR. The filing index links above go to sec.gov.